Advertisement

Index by Author

July 1996; 45 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abdel-Halim, S M

    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

B

  1. Beck-Nielsen, H

    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  2. Berggren, P O

    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

  3. Bier, D

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863
    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  4. Bollen, M

    • The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes July 1996 45:980-983; doi:10.2337/diabetes.45.7.980

  5. Bonadonna, R C

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  6. Bonora, E

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  7. Bruni, N

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

  8. Bucci, A

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

C

  1. Caro, J F

    • The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes July 1996 45:992-994; doi:10.2337/diabetes.45.7.992

  2. Chase, H P

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  3. Christianson, G J

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  4. Christie, M R

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  5. Cobelli, C

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  6. Collins, H

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

  7. Considine, E L

    • The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes July 1996 45:992-994; doi:10.2337/diabetes.45.7.992

  8. Considine, R V

    • The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes July 1996 45:992-994; doi:10.2337/diabetes.45.7.992

  9. Coppack, S W

    • Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes July 1996 45:984-987; doi:10.2337/diabetes.45.7.984

  10. Croitoru, K

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

D

  1. Dailey, G

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  2. Daniele, N

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

  3. DeFronzo, R A

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  4. Del Prato, S

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  5. Dick, G M

    • Effects of a physiological insulin concentration on the endothelin-sensitive Ca2+ store in porcine coronary artery smooth muscle. Diabetes July 1996 45:876-880; doi:10.2337/diabetes.45.7.876

  6. Dudley, M E

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  7. Dukes, I D

    • K+ channels: generating excitement in pancreatic beta-cells. Diabetes July 1996 45:845-853; doi:10.2337/diabetes.45.7.845

E

  1. Efendić, S

    • Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes July 1996 45:886-890; doi:10.2337/diabetes.45.7.886
    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

  2. Eisenbarth, G S

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  3. Ekstrand, A

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  4. Elliott, T

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

F

  1. Ferrannini, E

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915
    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  2. Flier, J S

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

  3. Franssila-Kallunki, A

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  4. Frascerra, S

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  5. Frederich, R C

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

  6. Friedman, R

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  7. Füchtenbusch, M

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  8. Fujisawa, K

    • Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes July 1996 45:954-959; doi:10.2337/diabetes.45.7.954

G

  1. Gallichan, W S

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  2. Gao, Z

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

  3. Gautier, N

    • Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes July 1996 45:869-875; doi:10.2337/diabetes.45.7.869

  4. Gerich, J

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  5. Gianani, R

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  6. Groop, P H

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  7. Guenifi, A

    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

  8. Gulli, G

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

H

  1. Hanabusa, T

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  2. Havel, P J

    • Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes July 1996 45:960-966; doi:10.2337/diabetes.45.7.960

  3. Hawkes, C J

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  4. Heydrick, S J

    • Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes July 1996 45:869-875; doi:10.2337/diabetes.45.7.869

  5. Hurel, S

    • Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes July 1996 45:881-885; doi:10.2337/diabetes.45.7.881

  6. Hyde, T M

    • The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes July 1996 45:992-994; doi:10.2337/diabetes.45.7.992

J

  1. Jackson, R A

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  2. Jansson, P A

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  3. Jenssen, T

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  4. Jullien, D

    • Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes July 1996 45:869-875; doi:10.2337/diabetes.45.7.869

K

  1. Kawasaki, E

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  2. Khan, A

    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

  3. Klein, S

    • Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes July 1996 45:984-987; doi:10.2337/diabetes.45.7.984
    • Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes July 1996 45:988-991; doi:10.2337/diabetes.45.7.988

  4. Konrad, R J

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

L

  1. Laakso, M

    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  2. Landt, M

    • Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes July 1996 45:984-987; doi:10.2337/diabetes.45.7.984
    • Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes July 1996 45:988-991; doi:10.2337/diabetes.45.7.988

  3. Larsson, O

    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

  4. Leiter, E H

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  5. Le Marchand-Brustel, Y

    • Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes July 1996 45:869-875; doi:10.2337/diabetes.45.7.869

  6. Lowell, B B

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

M

  1. MacDonald, M J

    • Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes July 1996 45:886-890; doi:10.2337/diabetes.45.7.886

  2. Mantzoros, C S

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

  3. Maratos-Flier, E

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

  4. Matschinsky, F M

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

  5. Minassian, C

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

  6. Mithieux, G

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

  7. Mizuno, A

    • Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes July 1996 45:941-946; doi:10.2337/diabetes.45.7.941

  8. Mohamed-Ali, V

    • Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes July 1996 45:984-987; doi:10.2337/diabetes.45.7.984

  9. Morohoshi, M

    • Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes July 1996 45:954-959; doi:10.2337/diabetes.45.7.954

N

  1. Nanjo, K

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  2. Natali, A

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  3. Newkirk, J

    • Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes July 1996 45:881-885; doi:10.2337/diabetes.45.7.881

  4. Noma, Y

    • Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes July 1996 45:941-946; doi:10.2337/diabetes.45.7.941

  5. Numano, F

    • Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes July 1996 45:954-959; doi:10.2337/diabetes.45.7.954

  6. Nurjhan, N

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

O

  1. Ofei, F

    • Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes July 1996 45:881-885; doi:10.2337/diabetes.45.7.881

  2. Ohagi, S

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  3. Ostenson, C G

    • Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes July 1996 45:886-890; doi:10.2337/diabetes.45.7.886
    • Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Diabetes July 1996 45:934-940; doi:10.2337/diabetes.45.7.934

P

  1. Paolisso, G

    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  2. Payton, M A

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  3. Pecori, N

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  4. Perriello, G

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  5. Philipson, L H

    • K+ channels: generating excitement in pancreatic beta-cells. Diabetes July 1996 45:845-853; doi:10.2337/diabetes.45.7.845

  6. Pietropaolo, M

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

Q

  1. Qu, D

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

R

  1. Roll, U

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  2. Roopenian, D C

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  3. Rosenthal, K L

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  4. Rothenberg, P L

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

S

  1. Saccomani, M P

    • Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes July 1996 45:915-925; doi:10.2337/diabetes.45.7.915

  2. Sakaguchi, H

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  3. Sanke, T

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  4. Sano, T

    • Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes July 1996 45:941-946; doi:10.2337/diabetes.45.7.941

  5. Segal, K R

    • Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes July 1996 45:988-991; doi:10.2337/diabetes.45.7.988

  6. Serreze, D V

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  7. Shima, K

    • Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes July 1996 45:941-946; doi:10.2337/diabetes.45.7.941

  8. Smith, U

    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  9. Snider, D P

    • MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice. Diabetes July 1996 45:902-908; doi:10.2337/diabetes.45.7.902

  10. Sopwith, M

    • Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes July 1996 45:881-885; doi:10.2337/diabetes.45.7.881

  11. Stalmans, W

    • The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes July 1996 45:980-983; doi:10.2337/diabetes.45.7.980

  12. Stefan, C

    • The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes July 1996 45:980-983; doi:10.2337/diabetes.45.7.980

  13. Stumvoll, M

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  14. Sturek, M

    • Effects of a physiological insulin concentration on the endothelin-sensitive Ca2+ store in porcine coronary artery smooth muscle. Diabetes July 1996 45:876-880; doi:10.2337/diabetes.45.7.876

  15. Susulic, V S

    • Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes July 1996 45:909-914; doi:10.2337/diabetes.45.7.909

T

  1. Taskinen, M R

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  2. Tatsuta, H

    • Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes July 1996 45:897-901; doi:10.2337/diabetes.45.7.897

  3. Taylor, R

    • Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes July 1996 45:881-885; doi:10.2337/diabetes.45.7.881

U

  1. Uchimura, I

    • Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes July 1996 45:954-959; doi:10.2337/diabetes.45.7.954

V

  1. Valverde, C

    • Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys. Diabetes July 1996 45:960-966; doi:10.2337/diabetes.45.7.960

  2. Van Obberghen, E

    • Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice. Diabetes July 1996 45:869-875; doi:10.2337/diabetes.45.7.869

  3. Verge, C F

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

  4. Viberti, G C

    • Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes July 1996 45:974-979; doi:10.2337/diabetes.45.7.974

  5. Vichi, S

    • Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes July 1996 45:947-953; doi:10.2337/diabetes.45.7.947

  6. Vidal, H

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

W

  1. Welle, S

    • Glutamine and alanine metabolism in NIDDM. Diabetes July 1996 45:863-868; doi:10.2337/diabetes.45.7.863

  2. Wera, S

    • The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes July 1996 45:980-983; doi:10.2337/diabetes.45.7.980

  3. Williams, C J

    • The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes July 1996 45:992-994; doi:10.2337/diabetes.45.7.992

  4. Wolf, B A

    • Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes July 1996 45:854-862; doi:10.2337/diabetes.45.7.854

Y

  1. Yu, L

    • Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes July 1996 45:926-933; doi:10.2337/diabetes.45.7.926

Z

  1. Zhu, M

    • Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM. Diabetes July 1996 45:941-946; doi:10.2337/diabetes.45.7.941

  2. Ziegler, A G

    • Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes July 1996 45:967-973; doi:10.2337/diabetes.45.7.967

  3. Zitoun, C

    • Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes July 1996 45:891-896; doi:10.2337/diabetes.45.7.891

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement